-
Firm Masters greens make life hard on golf's finest
-
Defending champ McIlroy shares Masters lead after back-nine birdie run
-
After oil, Venezuela opens up mining to private investors
-
Tigers' Meadows in hospital after colliding with teammate
-
US to host Israel-Lebanon talks as strikes threaten Iran ceasefire
-
'Scrappy' McIlroy leans on experience for share of Masters lead
-
Ukraine and Russia will cease fire for Orthodox Easter
-
Mateta inspires Palace win over Fiorentina in Conference League
-
Pioneering US hip-hop artist Afrika Bambaataa dies at 68
-
Russia bans Nobel-winning rights group, raids independent newspaper, in one day
-
Pentagon denies giving Vatican envoy 'bitter lecture'
-
Watkins propels Villa towards Europa League semis, Forest hold Porto
-
Aston Villa on verge of Europa League semis after beating Bologna
-
Venezuela police clash with protesters demanding salary rises
-
CAF president rejects corruption claims by Senegal
-
Israel and Lebanon set for ceasefire talks next week, says US official
-
US stocks extend gains, shrugging off ceasefire worries
-
IMF chief urges nations to 'do no harm' in fiscal response to Iran war
-
Sixers' Embiid to have surgery for appendicitis - team
-
Russian police raid independent Novaya Gazeta outlet, reporter detained
-
Former heavyweight king Fury adamant 'I've still got it' as Makhmudov awaits
-
Shipping toll for Hormuz passage sharply divides nations
-
McIlroy's back-nine birdie run grabs share of Masters lead
-
Melania Trump blasts 'lies' linking her to Epstein
-
'Anxious' Tatum back at Madison Square Garden with NBA East second seed on line
-
Strait of Hormuz traffic remains becalmed despite ceasefire
-
Melania Trump denies any links to Epstein abuse
-
American Airlines targets April 30 return to Venezuela
-
Venezuela police tear-gas protesters demanding salary rises
-
Robertson to leave Liverpool at end of season
-
Choudhary smashes Lucknow to dramatic IPL win over Kolkata
-
Sean 'Diddy' Combs asks US appeals court to overturn sentence
-
Verstappen Red Bull future in doubt as engineer to join McLaren
-
France's Macron in Rome for first meeting with Pope Leo
-
Angola name former Senegal boss Cisse as new coach
-
Sinner and Alcaraz wobble but advance to Monte Carlo quarter-finals
-
Reed soars to early Masters lead on wings of eagles
-
US Democrats fail in bid to curb Trump's Iran war powers
-
Veteran prop Slimani to return to France with Toulon
-
Iranians pay tribute to slain supreme leader weeks after killing
-
Russian police raid independent Novaya Gazeta media outlet
-
Barton Snow completes Cheltenham-Aintree double in Foxhunters Chase
-
IMF to cut global growth forecast due to Mideast war
-
Jihadists kill Nigerian troops including senior brigadier general
-
Local boy Aranburu sprints to Basque Country stage, Seixas extends lead
-
Russia brands Nobel Prize-winning rights group Memorial 'extremist'
-
England set for World Cup warm-up friendlies in Florida heat
-
Sabalenka pulls out of Stuttgart Open with injury
-
BTS kick off world tour with spectacular South Korea show
-
UK animal charity rescues over 250 dogs from single home
NDT Pharmaceuticals Completes Acquisition of Good Salt(TM) Life, LLC
ATHENS, GA / ACCESS Newswire / September 9, 2025 / NDT Pharmaceuticals Inc. (OTC:NDTP) ("NDTP" or the "Company") today announced that it has completed the acquisition of Good Salt Life, LLC, an Athens, Georgia-based innovator in biosafety and infection control. The transaction closed on Friday, September 5, 2025.
Good Salt Life, a wholly owned subsidiary of NDTP, is a vertically integrated biosafety company that designs, manufactures, and deploys infection control ecosystems combining proprietary hardware, EPA-approved chemistries, and data-driven disinfection protocols. Its solutions serve both animal and human environments across 11 countries and 8 industries, with customers ranging from food producers and hospitals to cruise lines and major sports organizations.
Good Salt Life's brand ecosystem spans consumer pet care, home care, cosmetics, antimicrobial chemistry, and cutting edge chemical delivery technology, including products trusted by leading institutions such as Merck Animal Health, United Airlines, Carnival Cruise Line, Marriott, and the NFL.
"This acquisition marks a transformative moment for NDTP," said Zach O'Shea, President and CEO of NDT Pharmaceuticals. "Good Salt Life's mission of combining sustainability, innovation, and wellness aligns perfectly with our vision for growth. Together, we are building a company that is not only committed to shareholder value but also to creating cleaner, safer, and healthier solutions for everyday life."
Additional details on the transaction and integration plans will be shared in the coming weeks.
About NDT Pharmaceuticals, Inc. (OTC:NDTP)
NDT Pharmaceuticals, Inc. (OTC:NDTP) is a publicly traded company focused on advancing innovative consumer health and wellness solutions. With its recent acquisition of Good Salt Life Inc., NDTP has expanded its strategic direction into sustainable, science-driven products that promote healthier living. The Company is committed to building value through investments in brands that protect people, pets, and the planet while aligning with growing consumer demand for eco-friendly and health-conscious alternatives.
About Good Salt Life, LLC
Good Salt Life, LLC is dedicated to promoting vitality through eco-friendly, nature-derived products that support healthier living environments. With a focus on innovation and sustainability, the company offers safe and effective solutions for home, pet, personal care, and animal health. Through strategic partnerships, including collaborations in the B2B animal health sector, Good Salt Life, LLC continues to drive advancements that benefit both people and animals. For more information, visit www.goodsaltlife.com.
Forward-Looking Statements
This press release contains forward-looking statements, as that term is defined in the Private Litigation Reform Act of 1995, that involve significant risks and uncertainties. Forward-looking statements can be identified through the use of words such as "may," "might," "will," "intend," "should," "could," "can," "would," "continue," "expect," "believe," "anticipate," "estimate," "predict," "outlook," "potential," "plan," "seek," and similar expressions and variations or the negatives of these terms or other comparable terminology. Readers are cautioned not to place undue reliance on these forward-looking statements, which reflect the Company's current expectations and speak only as of the date of this release. Actual results may differ materially from the Company's current expectations. Except as required by law, the Company does not undertake any responsibility to revise or update any forward-looking statements.
Contact:
[email protected]
SOURCE: NDT Pharmaceuticals Inc.
View the original press release on ACCESS Newswire
E.Flores--AT